"LOspedale Cardinale Panico Casa di Betania Hospice Onlus si prende cura del malato seguendolo durante tutto il percorso medico e offrendo servizi di alto livello qualitativo. LOspedale è proiettato nel futuro per essere al passo con il progresso e utilizza macchinari e tecnologie all'avanguardia. Tra le specializzazioni di cui si occupa: allergologia, oncologia, cardiologia, gastroenterologia, ginecologia, radiologia, ematologia, pediatria, oculistica ed effettuano visite ed esami specialistici di vario genere. Propongono il servizio di pronto soccorso attivo 24 ore su 24; offrono assistenza ai malati terminali. La struttura collabora con uno staff medico altamente preparato e competente."

During the past decade, Azienda Ospedaliera Card. G. Panico conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 5 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliera Card. G. Panico" #1 sponsor was "Azienda Ospedaliera Cardinale G. Panico" with 6 trials, followed by "Gruppo Italiano Trapianto di Midollo Osseo" with 5 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 4 trials sponsored, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 4 trials sponsored and "Fondazione Italiana Sindromi Mielodisplastiche-ETS" with 4 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliera Card. G. Panico" #1 collaborator was "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator and "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera Card. G. Panico" are "Alzheimer's Disease" (3 trials), "Heart Failure" (3 trials), "Atrial Fibrillation" (2 trials), "Follicular Lymphoma" (2 trials) and "Myelodysplastic Syndromes" (2 trials). Many other conditions were trialed in "Azienda Ospedaliera Card. G. Panico" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliera Card. G. Panico" are "Drug" (24 trials), "Other" (7 trials), "Device" (4 trials), "Procedure" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Cyclophosphamide" (2 trials), "Doxorubicin" (2 trials), "No intervention" (2 trials) and "Obinutuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliera Card. G. Panico" are 41 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Azienda Ospedaliera Card. G. Panico". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Azienda Ospedaliera Card. G. Panico, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliera Card. G. Panico, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".